About
Technology
Issues
FAQ
Links
Official Page
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent
in vivo
antitumor activity
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.